
Keywords: ASCT; autologous stem cell transplant; CR; complete response; CT; computed tomography; DPd; daratumumab, pomalidomide, and dexamethasone; DRd; daratumumab, lenalidomide, and dexamethasone; DVd; daratumumab, bortezomib, and dexamethasone; ERd; elotuzumab,